ID   ALG12_HUMAN             Reviewed;         488 AA.
AC   Q9BV10; A6PWM1; Q4KMH4; Q8NG10; Q96AA4;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   10-MAY-2017, entry version 144.
DE   RecName: Full=Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase;
DE            EC=2.4.1.260;
DE   AltName: Full=Asparagine-linked glycosylation protein 12 homolog;
DE            Short=hALG12;
DE   AltName: Full=Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase;
DE   AltName: Full=Mannosyltransferase ALG12 homolog;
DE   AltName: Full=Membrane protein SB87;
GN   Name=ALG12; ORFNames=PP14673;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT CDG1G VAL-142.
RC   TISSUE=Skin;
RX   PubMed=11983712; DOI=10.1074/jbc.M203285200;
RA   Chantret I., Dupre T., Delenda C., Bucher S., Dancourt J., Barnier A.,
RA   Charollais A., Heron D., Bader-Meunier B., Danos O., Seta N.,
RA   Durand G., Oriol R., Codogno P., Moore S.E.H.;
RT   "Congenital disorders of glycosylation type Ig is defined by a
RT   deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl
RT   mannosyltransferase.";
RL   J. Biol. Chem. 277:25815-25822(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zhang W., Li N., Wan T., Cao X.;
RT   "Identification of novel membrane proteins.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-393.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   CHARACTERIZATION OF VARIANTS CDG1G MET-67 AND GLN-146.
RX   PubMed=12217961; DOI=10.1093/hmg/11.19.2331;
RA   Grubenmann C.E., Frank C.G., Kjaergaard S., Berger E.G., Aebi M.,
RA   Hennet T.;
RT   "ALG12 mannosyltransferase defect in congenital disorder of
RT   glycosylation type Ig.";
RL   Hum. Mol. Genet. 11:2331-2339(2002).
RN   [9]
RP   CHARACTERIZATION OF VARIANT CDG1G PRO-158.
RX   PubMed=12093361; DOI=10.1042/BJ20020794;
RA   Thiel C., Schwarz M., Hasilik M., Grieben U., Hanefeld F., Lehle L.,
RA   von Figura K., Koerner C.;
RT   "Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl
RT   mannosyltransferase causes congenital disorder of glycosylation type
RT   Ig.";
RL   Biochem. J. 367:195-201(2002).
RN   [10]
RP   INVOLVEMENT IN CDG1G.
RX   PubMed=12736397; DOI=10.1203/01.PDR.0000072327.55955.F7;
RA   Zdebska E., Bader-Meunier B., Schischmanoff P.-O., Dupre T., Seta N.,
RA   Tchernia G., Koscielak J., Delaunay J.;
RT   "Abnormal glycosylation of red cell membrane band 3 in the congenital
RT   disorder of glycosylation Ig.";
RL   Pediatr. Res. 54:224-229(2003).
RN   [11]
RP   VARIANTS CDG1G ARG-101 AND GLN-146.
RX   PubMed=17506107; DOI=10.1002/ajmg.a.31791;
RA   Kranz C., Basinger A.A., Guecsavas-Calikoglu M., Sun L., Powell C.M.,
RA   Henderson F.W., Aylsworth A.S., Freeze H.H.;
RT   "Expanding spectrum of congenital disorder of glycosylation Ig (CDG-
RT   Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia,
RT   cardiomyopathy, genital malformations, and early lethality.";
RL   Am. J. Med. Genet. A 143:1371-1378(2007).
CC   -!- FUNCTION: Adds the eighth mannose residue in an alpha-1,6 linkage
CC       onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-
CC       Man(7)GlcNAc(2)) required for protein glycosylation.
CC   -!- CATALYTIC ACTIVITY: Dolichyl beta-D-mannosyl phosphate + D-Man-
CC       alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-
CC       (1->2)-D-Man-alpha-(1->3)-D-Man-alpha-(1->6))-D-Man-beta-(1->4)-D-
CC       GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol = D-Man-alpha-
CC       (1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-
CC       D-Man-alpha-(1->3)-(D-Man-alpha-(1->6))-D-Man-alpha-(1->6))-D-Man-
CC       beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol +
CC       dolichyl phosphate.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in fibroblasts.
CC   -!- DISEASE: Congenital disorder of glycosylation 1G (CDG1G)
CC       [MIM:607143]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:11983712,
CC       ECO:0000269|PubMed:12093361, ECO:0000269|PubMed:12217961,
CC       ECO:0000269|PubMed:12736397, ECO:0000269|PubMed:17506107}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 22 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAM94900.1; Type=Frameshift; Positions=468; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ290427; CAC83681.1; -; mRNA.
DR   EMBL; AJ303120; CAC67488.1; -; mRNA.
DR   EMBL; AF311904; AAM94900.1; ALT_FRAME; mRNA.
DR   EMBL; AF318343; AAL55850.1; -; mRNA.
DR   EMBL; CR456369; CAG30255.1; -; mRNA.
DR   EMBL; AL671710; CAO72064.1; -; Genomic_DNA.
DR   EMBL; CH471138; EAW73480.1; -; Genomic_DNA.
DR   EMBL; BC001729; AAH01729.1; -; mRNA.
DR   EMBL; BC098562; AAH98562.1; -; mRNA.
DR   CCDS; CCDS14081.1; -.
DR   RefSeq; NP_077010.1; NM_024105.3.
DR   UniGene; Hs.526711; -.
DR   ProteinModelPortal; Q9BV10; -.
DR   BioGrid; 122535; 9.
DR   IntAct; Q9BV10; 2.
DR   STRING; 9606.ENSP00000333813; -.
DR   CAZy; GT22; Glycosyltransferase Family 22.
DR   iPTMnet; Q9BV10; -.
DR   PhosphoSitePlus; Q9BV10; -.
DR   BioMuta; ALG12; -.
DR   DMDM; 45476971; -.
DR   EPD; Q9BV10; -.
DR   MaxQB; Q9BV10; -.
DR   PaxDb; Q9BV10; -.
DR   PeptideAtlas; Q9BV10; -.
DR   PRIDE; Q9BV10; -.
DR   DNASU; 79087; -.
DR   Ensembl; ENST00000330817; ENSP00000333813; ENSG00000182858.
DR   GeneID; 79087; -.
DR   KEGG; hsa:79087; -.
DR   UCSC; uc003biy.4; human.
DR   CTD; 79087; -.
DR   DisGeNET; 79087; -.
DR   GeneCards; ALG12; -.
DR   GeneReviews; ALG12; -.
DR   H-InvDB; HIX0175449; -.
DR   HGNC; HGNC:19358; ALG12.
DR   HPA; HPA003076; -.
DR   HPA; HPA051665; -.
DR   MalaCards; ALG12; -.
DR   MIM; 607143; phenotype.
DR   MIM; 607144; gene.
DR   neXtProt; NX_Q9BV10; -.
DR   OpenTargets; ENSG00000182858; -.
DR   Orphanet; 79324; ALG12-CDG.
DR   PharmGKB; PA134987771; -.
DR   eggNOG; KOG2516; Eukaryota.
DR   eggNOG; ENOG410XR38; LUCA.
DR   GeneTree; ENSGT00550000075005; -.
DR   HOGENOM; HOG000265945; -.
DR   HOVERGEN; HBG050486; -.
DR   InParanoid; Q9BV10; -.
DR   KO; K03847; -.
DR   OMA; NWRYDKR; -.
DR   OrthoDB; EOG091G07LQ; -.
DR   PhylomeDB; Q9BV10; -.
DR   TreeFam; TF314453; -.
DR   BRENDA; 2.4.1.260; 2681.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; ALG12; human.
DR   GeneWiki; ALG12; -.
DR   GenomeRNAi; 79087; -.
DR   PRO; PR:Q9BV10; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000182858; -.
DR   CleanEx; HS_ALG12; -.
DR   ExpressionAtlas; Q9BV10; baseline and differential.
DR   Genevisible; Q9BV10; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0000009; F:alpha-1,6-mannosyltransferase activity; IC:UniProtKB.
DR   GO; GO:0052917; F:dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000030; F:mannosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IDA:MGI.
DR   GO; GO:0006457; P:protein folding; NAS:UniProtKB.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR005599; GPI_mannosylTrfase.
DR   PANTHER; PTHR22760; PTHR22760; 1.
DR   Pfam; PF03901; Glyco_transf_22; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Congenital disorder of glycosylation;
KW   Disease mutation; Endoplasmic reticulum; Glycosyltransferase;
KW   Membrane; Polymorphism; Reference proteome; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    488       Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-
FT                                1,6-mannosyltransferase.
FT                                /FTId=PRO_0000215781.
FT   TRANSMEM     11     31       Helical. {ECO:0000255}.
FT   TRANSMEM     68     88       Helical. {ECO:0000255}.
FT   TRANSMEM     93    113       Helical. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical. {ECO:0000255}.
FT   TRANSMEM    145    165       Helical. {ECO:0000255}.
FT   TRANSMEM    177    197       Helical. {ECO:0000255}.
FT   TRANSMEM    212    232       Helical. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TRANSMEM    290    310       Helical. {ECO:0000255}.
FT   TRANSMEM    312    332       Helical. {ECO:0000255}.
FT   TRANSMEM    346    366       Helical. {ECO:0000255}.
FT   TRANSMEM    423    443       Helical. {ECO:0000255}.
FT   VARIANT      67     67       T -> M (in CDG1G; dbSNP:rs121907931).
FT                                {ECO:0000269|PubMed:12217961}.
FT                                /FTId=VAR_017904.
FT   VARIANT     101    101       G -> R (in CDG1G; dbSNP:rs121907933).
FT                                {ECO:0000269|PubMed:17506107}.
FT                                /FTId=VAR_038428.
FT   VARIANT     142    142       F -> V (in CDG1G; dbSNP:rs28942090).
FT                                {ECO:0000269|PubMed:11983712}.
FT                                /FTId=VAR_017905.
FT   VARIANT     146    146       R -> Q (in CDG1G; dbSNP:rs121907932).
FT                                {ECO:0000269|PubMed:12217961,
FT                                ECO:0000269|PubMed:17506107}.
FT                                /FTId=VAR_017906.
FT   VARIANT     158    158       L -> P (in CDG1G; dbSNP:rs121907934).
FT                                {ECO:0000269|PubMed:12093361}.
FT                                /FTId=VAR_017907.
FT   VARIANT     393    393       I -> V (in dbSNP:rs3922872).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_024466.
FT   CONFLICT    267    267       A -> T (in Ref. 2; AAM94900).
FT                                {ECO:0000305}.
SQ   SEQUENCE   488 AA;  54655 MW;  8D4F921C21CBC8B6 CRC64;
     MAGKGSSGRR PLLLGLLVAV ATVHLVICPY TKVEESFNLQ ATHDLLYHWQ DLEQYDHLEF
     PGVVPRTFLG PVVIAVFSSP AVYVLSLLEM SKFYSQLIVR GVLGLGVIFG LWTLQKEVRR
     HFGAMVATMF CWVTAMQFHL MFYCTRTLPN VLALPVVLLA LAAWLRHEWA RFIWLSAFAI
     IVFRVELCLF LGLLLLLALG NRKVSVVRAL RHAVPAGILC LGLTVAVDSY FWRQLTWPEG
     KVLWYNTVLN KSSNWGTSPL LWYFYSALPR GLGCSLLFIP LGLVDRRTHA PTVLALGFMA
     LYSLLPHKEL RFIIYAFPML NITAARGCSY LLNNYKKSWL YKAGSLLVIG HLVVNAAYSA
     TALYVSHFNY PGGVAMQRLH QLVPPQTDVL LHIDVAAAQT GVSRFLQVNS AWRYDKREDV
     QPGTGMLAYT HILMEAAPGL LALYRDTHRV LASVVGTTGV SLNLTQLPPF NVHLQTKLVL
     LERLPRPS
//
